A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the long-term safety of saredutant (or SR48968C) in
adult and elderly patients with depression.The primary objective is to evaluate the long-term
safety and tolerability of a 100 mg dose of saredutant in adult and elderly patients with
depression. The secondary objective is to evaluate blood levels of saredutant.